233 related articles for article (PubMed ID: 22091305)
1. The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.
Mehrabian F; Khani B; Kelishadi R; Kermani N
J Res Med Sci; 2011 Jun; 16(6):763-9. PubMed ID: 22091305
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
[TBL] [Abstract][Full Text] [Related]
3. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
Goverde AJ; van Koert AJ; Eijkemans MJ; Knauff EA; Westerveld HE; Fauser BC; Broekmans FJ
Hum Reprod; 2009 Mar; 24(3):710-7. PubMed ID: 19095675
[TBL] [Abstract][Full Text] [Related]
4. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
5. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.
Hosseinpanah F; Barzin M; Keihani S; Ramezani Tehrani F; Azizi F
Clin Endocrinol (Oxf); 2014 Jul; 81(1):93-9. PubMed ID: 24428207
[TBL] [Abstract][Full Text] [Related]
6. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
[TBL] [Abstract][Full Text] [Related]
7. The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study.
Hosseinpanah F; Barzin M; Tehrani FR; Azizi F
Clin Endocrinol (Oxf); 2011 Nov; 75(5):692-7. PubMed ID: 21592169
[TBL] [Abstract][Full Text] [Related]
8. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?
Behboudi-Gandevani S; Ramezani Tehrani F; Cheraghi L; Azizi F
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():110-4. PubMed ID: 27579518
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study.
Zaeemzadeh N; Sadatmahalleh SJ; Ziaei S; Kazemnejad A; Mottaghi A; Mohamadzadeh N; Movahedinejad M
Int J Reprod Biomed; 2020 Apr; 18(4):253-264. PubMed ID: 32494764
[TBL] [Abstract][Full Text] [Related]
10. [Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome].
Rehme MF; Pontes AG; Corrente JE; Franco JG; Pontes A
Rev Bras Ginecol Obstet; 2013 Dec; 35(12):562-8. PubMed ID: 24500511
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
Bil E; Dilbaz B; Cirik DA; Ozelci R; Ozkaya E; Dilbaz S
J Obstet Gynaecol Res; 2016 Jul; 42(7):837-43. PubMed ID: 27071345
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis.
Niksima SH; Odel NM; Khaki S; Ghanei Gheshlagh R; Fallahi A; Kurdi A
Diabetes Metab Syndr; 2019; 13(3):1911-1915. PubMed ID: 31235114
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
[TBL] [Abstract][Full Text] [Related]
14. Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.
Vaggopoulos V; Trakakis E; Chrelias C; Panagopoulos P; Basios G; Makridima S; Sioulas VD; Simeonides G; Labos G; Boutati E; Kassanos D
J Endocrinol Invest; 2013; 36(7):478-84. PubMed ID: 23211631
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome in women with polycystic ovary syndrome and the factors associated: A cross sectional study at a tertiary care center in Hyderabad, south-eastern India.
Karee M; Gundabattula SR; Sashi L; Boorugu H; Chowdhury A
Diabetes Metab Syndr; 2020; 14(4):583-587. PubMed ID: 32416528
[TBL] [Abstract][Full Text] [Related]
16. Association of insulin resistance with polycystic ovary syndrome phenotypes and patients' characteristics: a cross-sectional study in Iran.
Rahmatnezhad L; Moghaddam-Banaem L; Behroozi-Lak T; Shiva A; Rasouli J
Reprod Biol Endocrinol; 2023 Nov; 21(1):113. PubMed ID: 38001527
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic subgroups of polycystic ovary syndrome have different intra-renal resistance symptoms.
Ciftci CF; Uckuyu A; Karadeli E; Turhan E; Toprak E; Ozcimen EE
Ginekol Pol; 2012 Dec; 83(12):910-5. PubMed ID: 23488293
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.
Kim MJ; Lim NK; Choi YM; Kim JJ; Hwang KR; Chae SJ; Park CW; Choi DS; Kang BM; Lee BS; Kim T; Park HY
PLoS One; 2014; 9(6):e99252. PubMed ID: 24901345
[TBL] [Abstract][Full Text] [Related]
20. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
